Zami Aberman - Director, Pluristem Therapeutics Inc

As of February 14, 2022


What is Zami Aberman's Net Worth?

The current estimated net worth of Pluristem Therapeutics Inc's Director, Zami Aberman, is estimated to be about $2.76M . Zami Aberman owns about 1,585,729 units of Pluristem Therapeutics Inc common stock. In the last 15 years at Pluristem Therapeutics Inc, Zami Aberman has sold an estimated value of $742.39K worth.

What is Zami Aberman's Past Insider Trading?

Zami Aberman's largest purchase order was 80,616 units , worth over $145.11K on February 14, 2022. Zami Aberman's largest sale order was 69,850 units , worth over $299.98K on January 14, 2014. In total, Zami Aberman has made about 36 transactions over 15 years of their time at Pluristem Therapeutics Inc. Zami Aberman usually trades in September and December, with the busiest year in 2014.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Zami Aberman's Salary in 2020?

As Director of Pluristem Therapeutics Inc, Zami Aberman has a total base salary of $439,704 . Zami Aberman received compensation valued at about $501,244 in 2020 after becoming Director. The vast majority of their compensation came in the form of other compensation of $61,540 .

What is Zami Aberman's' Mailing Address?

  • Mailing address is 63 Rabutzky Street Raanana L3 43220 Israel

Pluristem Therapeutics Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Compensation
Total
Zami Aberman 2020 $439,704 - $61,540 $501,244
Zami Aberman 2019 $551,137 $478,500 $66,857 $1,096,494
Yaky Yanay 2020 $320,911 - $29,466 $350,377
Yaky Yanay 2019 $396,632 $461,100 $29,253 $886,985
Chen Franco-Yehuda 2020 $179,229 - $28,461 $207,690
Chen Franco-Yehuda 2019 $78,889 $112,329 $13,599 $204,817
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1158780/000121390021020786/ea139144-def14a_pluristem.htm

What are Pluristem Therapeutics Inc's Past Insider Trades?

Pluristem Therapeutics Inc's most recent insider trade came on February 14, 2022 by Zami Aberman who bought 80,616 units worth $145.11K . In the last 14 years, insiders at Pluristem Therapeutics Inc have sold an estimated value of $7.29M and bought an estimated value of $14.34M worth of shares. Insider trading is most common in December, with the busiest year in 2009. The most active traders at the company are Zami Aberman, Director,  Yaky Yanay, CEO & President,  and Israel Ben-Yoram, Director .

PAM TRANSPORTATION SERVICES INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1